Additional Information
Market: AIM
Sector: Software & Computer Services
EPIC: AVIA
Latest Price: 8.63p  (0,00%)
52-week High: 45.25p
52-week Low: 5.75p
Market Cap: 0.55M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Avia Health Informatics
www.ahi-plc.com/index.html

 

Avia Health Informatics Plc ("Avia") was incorporated in the UK, which is also its main country of operation.

Avia, via its trading subsidiary Plain Healthcare Limited ("Plain"), develops, supports and maintains the Odyssey clinical decision support software products and systems.

The Odyssey software product range is for use by clinicians and non-clinicians in healthcare and non-healthcare markets in the UK and internationally.

 

Pdf

Avia makes push into Africa as it signs up two re-sellers in Nigeria

1st Mar 2011, 8:01 am The products Avia sells under the Odyssey brand promise to revolutionise the way people receive health advice.

 

Avia Health Informatics (LON:AVIA), the maker of clinical decision software and systems, has appointed two resellers in Nigeria.

They are AB Informatics and DeMiTAG Health Concepts, who will sell the company’s Odyssey diagnostics range.

AB dirctor Ayo Bamgboye said: "We are always looking for companies with a distinctive track record in the development of high quality clinical solutions that can support clinicians and health practitioners' decision making."

The products Avia sells under the Odyssey brand promise to revolutionise the way people receive health advice. 

They can be used for self-assessment on a touch screen device, or accessed via the internet by clinicians working over the telephone or directly with the patient.  

DeMiTAG chief executive Babajide Alabi said: "We are delighted to be appointed Odyssey reseller. 

“With the Nigerian government's recent efforts at revolutionising the health care sector, the introduction of Odyssey will go a long way in complementing these efforts. 

“Our clients are upbeat about how much Odyssey would contribute to their health services and delivery. We are excited too."

Avia’s high end database has been deployed by a local ambulance service to identify the most urgent cases and its software is also being utilised by receptionists and nurses in primary care centres. 

The programmes are based on the pioneering work of leading academic Professor Jeremy Dale, who is a director of Avia, a major shareholder and one of the original founders of Plain.

The software powered the NHS Direct helpline until 2000, when the contract was awarded to Axa Assistance and MDS International.

The products rely on a Bayesian, or statistics-based system of questions and answers that mimics human reasoning processes. Unlike decision support programmes which use algorithms, this is intended to make Odyssey much more intuitive to use.

Its creators say that patient assessments with Odyssey are faster and safer. They also cut down unnecessary hospital referrals and treatment costs.  

MobileAssess is the latest addition to the Odyssey stable. And the first product in the range is a programme called Odyssey MarineAssess, which is specifically targeted at global cargo shipping companies.

It is designed to save considerable costs associated with diverting or evacuating of a vessel in the event of injury to or illness of a crew member.

Under chairman Barry Giddings’ chairmanship the Avia developers have taken what used to be a very clunky system and made it fit for the internet era.

It can be downloaded or stored remotely using cloud-based computing. Customers don’t even need an always-on connection to the net, which is helpful for users in remote or developing parts of the world.

Not just this, the Odyssey system can be sliced, diced and served up in any form you want it – from the very basic suite you might get as a mobile app, to the more complex, all singing, all dancing service provided to  insurance call centres.

Contracts such as today’s the chairman’s decision to take the product global. Giddings said: “We are very pleased to have both AB Informatics and DeMiTAG HealthConcepts on board as resellers into the Nigerian territory and we are confident by continuing to build our international reseller network this will lead to further global sales of the Odyssey product range."


 

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.